A Metabolism-related Gene Signature for Predicting the Prognosis in Thyroid Carcinoma

Overview

Journal Front Genet

Date 2023 Jan 23

PMID 36685893

Authors

Qiujing Du

Ruhao Zhou

Heng Wang

Qian Li

Qi Yan

Wenjiao Dang

Jianjin Guo

Affiliations

Soon will be listed here.

Abstract

Metabolic reprogramming is one of the cancer hallmarks, important for the survival of malignant cells. We investigated the prognostic value of genes associated with metabolism in thyroid carcinoma (THCA). A prognostic risk model of metabolism-related genes (MRGs) was built and tested based on datasets in The Cancer Genome Atlas (TCGA), with univariate Cox regression analysis, LASSO, and multivariate Cox regression analysis. We used Kaplan-Meier (KM) curves, time-dependent receiver operating characteristic curves (ROC), a nomogram, concordance index (C-index) and restricted mean survival (RMS) to assess the performance of the risk model, indicating the splendid predictive performance. We established a three-gene risk model related to metabolism, consisting of , , and . The correlation analysis in patients with different risk statuses involved immune infiltration, mutation and therapeutic reaction. We also performed pan-cancer analyses of model genes to predict the mutational value in various cancers. Our metabolism-related risk model had a powerful predictive capability in the prognosis of THCA. This research will provide the fundamental data for further development of prognostic markers and individualized therapy in THCA.

References

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Zhang J, Zhang S, Li X, Pi H . Relationship of ITPKA expression with the prognosis of breast cancer. Mol Genet Genomic Med. 2021; 9(4):e1598. PMC: 8123748. DOI: 10.1002/mgg3.1598. View

Zhao F, Su J, Lun S, Hou Y, Duan L, Wang N . Association between polymorphisms in the genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China. Oncol Lett. 2019; 18(2):1267-1277. PMC: 6607096. DOI: 10.3892/ol.2019.10455. View

Wang Z, Dai J, Yan J, Zhang Y, Yin Z . Targeting EZH2 as a novel therapeutic strategy for sorafenib-resistant thyroid carcinoma. J Cell Mol Med. 2019; 23(7):4770-4778. PMC: 6584518. DOI: 10.1111/jcmm.14365. View

Zhu X, Xu A, Zhang Y, Huo N, Cong R, Ma L . ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway. Onco Targets Ther. 2020; 13:10515-10523. PMC: 7573328. DOI: 10.2147/OTT.S266095. View

Dey P, Kimmelman A, DePinho R . Metabolic Codependencies in the Tumor Microenvironment. Cancer Discov. 2021; 11(5):1067-1081. PMC: 8102306. DOI: 10.1158/2159-8290.CD-20-1211. View

Castro M, Bergert E, Goellner J, Hay I, Morris J . Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab. 2001; 86(11):5627-32. DOI: 10.1210/jcem.86.11.8048. View

Xu P, Xi Y, Zhu J, Zhang M, Luka Z, Stolz D . Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 2021; 161(1):271-286.e11. PMC: 8238844. DOI: 10.1053/j.gastro.2021.03.048. View

Han B, Yang X, Hosseini D, Luo P, Liu M, Xu X . Development and validation of a survival model for thyroid carcinoma based on autophagy-associated genes. Aging (Albany NY). 2020; 12(19):19129-19146. PMC: 7732287. DOI: 10.18632/aging.103715. View

10.

Windhorst S, Fliegert R, Blechner C, Mollmann K, Hosseini Z, Gunther T . Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities. J Biol Chem. 2009; 285(8):5541-54. PMC: 2820782. DOI: 10.1074/jbc.M109.047050. View

11.

Zhang P, Zhang L, Hou Z, Lin H, Gao H, Zhang L . Structural basis for the substrate recognition mechanism of ATP-sulfurylase domain of human PAPS synthase 2. Biochem Biophys Res Commun. 2021; 586:1-7. DOI: 10.1016/j.bbrc.2021.11.062. View

12.

GallegosVargas J, SanchezRoldan J, RonquilloSanchez M, Carmona Aparicio L, FlorianoSanchez E, CardenasRodriguez N . Gene Expression of CYP1A1 and its Possible Clinical Application in Thyroid Cancer Cases. Asian Pac J Cancer Prev. 2016; 17(7):3477-82. View

13.

Blechner C, Becker L, Fuchs H, Rathkolb B, Prehn C, Adler T . Physiological relevance of the neuronal isoform of inositol-1,4,5-trisphosphate 3-kinases in mice. Neurosci Lett. 2020; 735:135206. DOI: 10.1016/j.neulet.2020.135206. View

14.

Pucci S, Polidoro C, Greggi C, Amati F, Morini E, Murdocca M . Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes. Cell Death Dis. 2019; 10(2):53. PMC: 6362207. DOI: 10.1038/s41419-018-1279-1. View

15.

Kudhair B, Alabid N, Zayed K, Lafta I, Taheri-Kafrani A . The correlation of combined OGG1, CYP1A1 and GSTP1 gene variants and risk of lung cancer of male Iraqi waterpipe tobacco smokers. Mol Biol Rep. 2020; 47(7):5155-5163. DOI: 10.1007/s11033-020-05589-y. View

16.

Huang R, Li G, Wang Z, Hu H, Zeng F, Zhang K . Identification of an ATP metabolism-related signature associated with prognosis and immune microenvironment in gliomas. Cancer Sci. 2020; 111(7):2325-2335. PMC: 7385348. DOI: 10.1111/cas.14484. View

17.

Mariniello R, Orlandella F, De Stefano A, Iervolino P, Smaldone G, Luciano N . The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein. Int J Mol Sci. 2020; 21(3). PMC: 7037188. DOI: 10.3390/ijms21030702. View

18.

Zhang D, Guo Y, Xie N . Prognostic value and co-expression patterns of metabolic pathways in cancers. BMC Genomics. 2020; 21(Suppl 11):860. PMC: 7771089. DOI: 10.1186/s12864-020-07251-0. View

19.

Jung S, Lee H, Yu D, Kim B, Park S, Lee Y . Heparan sulfation is essential for the prevention of cellular senescence. Cell Death Differ. 2015; 23(3):417-29. PMC: 5072436. DOI: 10.1038/cdd.2015.107. View

20.

Naoum G, Morkos M, Kim B, Arafat W . Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol Cancer. 2018; 17(1):51. PMC: 5817719. DOI: 10.1186/s12943-018-0786-0. View